MAP2K2 and neoplasm: We previously identified GCIP as a new physiological substrate for MEK2, but not MEK1, showed that MEK2 directly phosphorylates GCIP at its Ser313 and Ser356 residues, and reported that this enhances proteasomal degradation to promote tumor cell proliferation and migration (46).